Yousif Capital Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.2M Buy
5,277
+43
+0.8% +$7.66K 0.01% 960
2026
Q1
$903K Sell
5,234
-2
-0% -$371 0.01% 1110
2025
Q4
$1.14M Sell
5,236
-301
-5% -$54.6K 0.01% 1015
2025
Q3
$866K Sell
5,537
-182
-3% -$28.9K 0.01% 1178
2025
Q2
$868K Buy
5,719
+32
+0.6% +$4.27K 0.01% 1202
2025
Q1
$856K Sell
5,687
-215
-4% -$36K 0.01% 1183
2024
Q4
$1.09M Sell
5,902
-181
-3% -$34.9K 0.01% 1099
2024
Q3
$1.2M Sell
6,083
-12
-0.2% -$2.49K 0.01% 1077
2024
Q2
$1.26M Sell
6,095
-82
-1% -$18.6K 0.01% 1000
2024
Q1
$1.67M Buy
6,177
+18
+0.3% +$4.3K 0.02% 901
2023
Q4
$1.46M Sell
6,159
-311
-5% -$61.2K 0.02% 1005
2023
Q3
$1.27M Sell
6,470
-117
-2% -$24K 0.02% 1011
2023
Q2
$1.38M Buy
6,587
+277
+4% +$55.1K 0.02% 978
2023
Q1
$1.27M Sell
6,310
-458
-7% -$104K 0.02% 1022
2022
Q4
$1.47M Sell
6,768
-2,174
-24% -$475K 0.02% 950
2022
Q3
$1.76M Sell
8,942
-99
-1% -$21.4K 0.03% 828
2022
Q2
$1.94M Sell
9,041
-20
-0.2% -$4.89K 0.03% 846
2022
Q1
$2.57M Sell
9,061
-80
-0.9% -$24.7K 0.03% 761
2021
Q4
$3.44M Buy
+9,141
New +$3.55M 0.04% 591

Other funds holding CRL

Yousif Capital Management's CRL Position: Q2 2026 in Review

Yousif Capital Management increased its Charles River Laboratories (CRL) stake by 0.82% in Q2 2026, buying an estimated $7.66K and bringing the position to 5,277 shares worth $1.2M. The position accounts for 0.01% of the portfolio, ranked #960.

Yousif Capital Management first reported a position in CRL in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.44M in Q4 2021. 81 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Yousif Capital Management held 5,277 shares of Charles River Laboratories worth $1.2M as of Q2 2026.
  • Yousif Capital Management bought 43 Charles River Laboratories shares in Q2 2026, an estimated $7.66K.
  • Charles River Laboratories made up 0.01% of Yousif Capital Management's portfolio in Q2 2026, its #960 holding.
  • Yousif Capital Management first reported a position in Charles River Laboratories in Q4 2021 and has held it in 19 quarters since.
  • Yousif Capital Management's Charles River Laboratories position peaked at $3.44M in Q4 2021.
  • 81 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.